News and Events Recent News Sep 1, 2021 Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences Aug 5, 2021 Arrowhead Pharmaceuticals Reports Fiscal 2021 Third Quarter Results Jul 29, 2021 Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease View More » Recent Events Sep 29, 2021 2021 Cantor Virtual Global Healthcare Conference Sep 14, 2021 Baird's 2021 Global Healthcare Conference Sep 13, 2021 HC Wainwright 23rd Annual Global Investment Conference View More »
Jul 29, 2021 Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease